Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 51, pseudogene (RN7SL51P)

Target
RN7SL51P
Molecular classification
Pseudogene
01

Overview

RN7SL51P is a genomic segment categorized as a pseudogene, sharing high sequence similarity with the functional 7SL RNA gene but lacking protein-coding capacity and biological function[1][6][7]. The canonical 7SL RNA is a conserved element of the signal recognition particle (SRP), which plays a central role in the co-translational targeting of proteins to the endoplasmic reticulum in eukaryotic cells[3][5]. Unlike functional 7SL RNA, pseudogenes such as RN7SL51P do not produce functional RNA molecules and are typically not expressed or translated; rather, they arise via gene duplication or retrotransposition, resulting in nonfunctional sequences[6][7]. Assessment of therapeutic target status and correctness: - RN7SL51P is *not* a therapeutic target, receptor, enzyme, transporter, or any other molecular entity with recognized druggable activity[1][6]. - The designation RN7SL51P is correct in terms of naming conventions for pseudogenes, but it is *not* a functional molecular target, so returning it as a therapeutic target would be incorrect. - There are no known biological functions, disease associations, interacting drugs, biomarker utility, or safety concerns directly attributed to RN7SL51P, in line with its status as a nonfunctional pseudogene[1][6][7]. If you seek information on the functional RNA molecule (7SL RNA, SRP RNA), refer to entries for "Signal recognition particle 7SL RNA," which is a key structural ribonucleoprotein in protein targeting, unlike pseudogene copies[3][5]. Summary: RN7SL51P is a pseudogene of 7SL RNA, with no protein product, biological function, or relevance as a therapeutic target[1][6][7].

Other names
7SL RNA pseudogene 51RN7SL51P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 51, pseudogene (RN7SL51P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 51, pseudogene (RN7SL51P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call